Clinical research organization India
clinical trials india Welcome

Your success. That’s our commitment at Excel Life Sciences. Everything we do is built around leveraging our expertise and passion to ensure that your clinical trials are successful. As the leading Trial Management Organization in India and through our trusted partnerships worldwide, we have the capabilities and bandwidth to take on any project large or small. And with offices and executive leadership based in the United States, you can be sure that we’re available when you are. Excel Life Sciences mixes a customized consultative approach with industry-leading experience and know-how to get results. Specifically our team’s experience includes:

  • 280 years combined experience in Clinical Medicine, Pharmaceutical Medicine and Biometrics
  • 50 years of regulatory experience and top USA and India regulatory executive’s on the ELS advisory board 
  • 350 successfully conducted clinical trials at over 1000 sites 
  • 135 IND approvals & 20+ NDA approvals in US, Europe & Asia
clinical trials india What's New at ELS

Excel Life Sciences Continues Successful Management of Clinical Trials in India as Regulators work to Improve Review Process

Excel Life Sciences President and Chief Medical Officer, Dr. Vijai Kumar, is featured in a just released story on the evolving clinical research landscape in India.  The article which appears in the web-based publication, eCliniqua, discusses some of the ongoing changes underway to create a more robust, efficient and predictable regulatory review process in India for clinical trials. Dr. Kumar shares information on the approach Excel Life Sciences takes to ensure timely regulatory approval for its clients global clinical trials. The company, with a unique operating model involving deployment of its own onsite clinical research coordinators to each site, prides itself on running ethical trials and delivering data quality and data integrity to its clients. Please click here to read the full article


Allergan Inc. Layoffs: Employees Tell Their Side Of The Story

GlaxoSmithKline May Separate Businesses

Layoffs Make Allergan Inc., Microsoft CEOs Look Like Heroes—And That's Why Corporate America Is Sick

Why Men Like Nice Women And Why Women Like Bad Boys, University of Rochester Study

Bay Area's PaxVax, Inc. Reels In Up To $60 Million Financing

Politicizing Gilead Sciences, Inc.'s R&D Solvadi Costs Is A Reckless And Dangerous Misadventure

FDA Rejects Redwood City's AcelRx Pharmaceuticals Painkiller Dispensing Device; Stock Plunges -34.35% At 9:37AM ET

Slow Walking Speed And Memory Issues Linked To Early Signs Of Dementia, Albert Einstein College of Medicine Study

20 Top-Paid Research Institute Leaders Of 2014

Zealand Pharma , Boehringer Ingelheim Corporation Strike $402 Million Peptide Pact

3 Future Biotech Blockbusters To Watch?

Google Inc.'s Next Project: The Human Body

AstraZeneca PLC Taps Roche For New Blood-Based Cancer Drug Tests

Shift Work Linked To Heightened Risk Of Type 2 Diabetes, Reveals

Clinuvel Snags A $95 Million Takeover Bid From New York-Based Retrophin, Inc.

Confirmed: Reckitt Benckiser Plc To Spin Off Heroin Treatment Business

FDA Approves Purdue Pharma L.P.???s Hard-to-Abuse Narcotic Painkiller

Rumor: Hospira, Inc. May Buy Medical-Nutrition Unit For $5 Billion

U.S. FDA Grants Regular (Full) Approval For Pharmacyclics, Inc.'s IMBRUVICA® For Two Indications

AstraZeneca PLC, QIAGEN N.V. Strike Lung Cancer Diagnostic Pact For Patients Suitable For Treatment With IRESSA

Celsion Corporation Shows Off Positive ThermoDox?? Data In Primary Liver Cancer Patients

Biodel Inc. Enters Into $15 Million Equity Commitment With

Management Reshuffle At Ranbaxy Laboratories: Promoted, New R&D Head Named

American Diabetes Association Announces Interim CEO

Bristol-Myers Squibb Company Taps Bay Area's Redwood City For Expansion, Pharma Giant To Increase Workforce

Novartis AG Layoffs: Game-Changing Tips For Today???s Job Seeker

Amgen, Bayer HealthCare's Nexavar Fails Late-Stage Breast Cancer Study

Bruker Corporation Discloses Plans To Sell California Unit And Lay Off Up To 250 Staffers

3 Quotes From Johnson & Johnson's Conference Call You Need To Read

Incyte Corporation's Jakafi Fails to Provide RELIEF In Phase 3 Trial

Sarepta Therapeutics Terminates Chief Science Officer As It Heads Toward Drug Approval

Amgen Nervous As FDA Paves Way For Novartis AG To Copy Drug Neupogen

Sources Reveal Reckitt Benckiser Plc Plans To Spinoff Virginia-Based Pharmaceutical Unit

AbbVie Trod Cautiously In Inversion Takeover Bid To Woo Drug Maker

Allegations Of GlaxoSmithKline Corruption Spread To Syria

4 Ways Gilead Sciences, Inc.???s Earnings Will Impact Every American

Massachusett's Ocular Therapeutix, Inc. Goes IPO At $13 A Share

Merck KGaA To Begin Construction Of $108 Million China Plant

The Ingredients Of "All Natural Foods" Will Terrify You

New Cambridge-Based Biotech VC Firm Emerges, Eyes $150 Million Fund

Reckitt Benckiser Plc To Invest €100 Million In Its Consumer Health R&D Operations, Will Create 1,200 New Jobs

Merck & Co., Inc. Cuts Another 600 Sales Reps

Scientists To Be Given Compounds Discarded By Pharma Companies

Study Claims Celgene Drug Can Drive HIV Out Of Hiding

AgeneBio Appoints Industry Leaders As Chairman Of The Board And As President And Chief Executive Officer

Marriage Of Diagnostics To New Therapies Breeds Biotech Winners

Total Darkness During The Night Is A Key To Success Of Breast Cancer Therapy, Tulane University Study

Kidney Dialysis Drug Phase 3 Data Boost Keryx Biopharmaceuticals's Hopes For U.S. Approval

Newly Discovered Gut Virus Lives In Half The World's Population, San Diego State University Study

Losing Your Job Could Kill You, But Recessions Could Be Good For Your Health, Drexel University And University of Michigan Study

Puma Biotechnology Shares Soar On Breast Cancer Drug Results

Merck KGaA Eyes Southeast Asia Plants To Cut Costs

GlaxoSmithKline Seeks Approval For First Ever Malaria Vaccination

Pain And Itch May Be Signs Of Skin Cancer, s Chair Of Dermatology Reveals

Paracetamol Does Not Work For Lower Back Pain, University of Sydney Study

Choice Bias: A Quirky Byproduct Of Learning From Reward, Brown University Study

Where Are The Unhappiest Cities In America? University of British Columbia Study

Bay Area's Intersect ENT Secures $55 Million After Hitting The Low End Of Its IPO Range

Rosemary And Oregano Contain Diabetes-Fighting Compounds, Reveals

What You Need To Know About The Listeria Fruit Recall

Do Drugmakers Use An FDA Safety Program To Thwart Generics?

More U.S. Teens' Report Using Human Growth Hormone

San Diego Biotech Pfenex Inc. Prices IPO At $6 Per Share, Below Downwardly Revised $8 Expectation

Centers for Disease Control and Prevention (CDC) Says Lab Director Behind Anthrax Mishap Resigns

GlaxoSmithKline CEO Has Bigger Problem Than China As Sales Drop

Poland Confirms Case Of African Swine Fever In Farm Pigs, Reveal

Hepatitis B Drug Rockets Gilead Sciences, Inc. Into The Big Leagues

Hikma Pharmaceuticals Buys Ben Venue Laboratories's Generic Manufacturing Site

Seattle Biotech Immune Design Corporation Prices IPO At $12 Per Share, The Low End Of The Range

India's Ipca Laboratories Halts Shipments To U.S. From Local Plant After FDA Concerns

Pfizer Inc. Backs Out of Funding Puma Biotechnology Cancer Drug Trials

Atox Bio Locks In $23 Million

Indian Boy Has 232 Teeth Removed

Amgen Growth In Brazil Picks Up, Eyes Doubling Portfolio By 2020

Gilead Sciences, Inc., Strike Deal: New Opportunity For Indian Drugmakers

Highest Paid Biopharma CEOs Not In The Triangle

Ligand Pharmaceuticals Inc. Partner GlaxoSmithKline Announces Record Quarterly Promacta™/Revolade™ Revenue Of $92 Million

Cubist Pharmaceuticals, Inc. Strikes Agreement With Competitor To Delay Generic Cubicin

Roche Profit Dented On Diagnostics Writedown

SoCal's Atara Biotherapeutics IPO Delayed By New Test Results

Boehringer Ingelheim GmbH Withheld Evidence On Blockbuster Blood Thinner

Bristol-Myers Squibb Company Appoints As India Country Head

Blueprint Medicines Appoints As Chief Executive Officer

Sysmex Corporation Appoints U.S. Subsidiary CEO To Executive Officer

Major Restructure At Allergan Inc. Amid Valeant Pharmaceuticals International Takeover Battle; To Cut 1,500 Jobs

Celsion Corporation Announces Positive Interim Data Update From Its Phase 2 DIGNITY Study In Breast Cancer

Innapharma: Completion Of Target Enrollment In The Phase 2 EffiKIR Trial

Alcohol Improves Your Sense Of Smell, Weizmann Institute of Science Study

Moderate Alcohol Use Associated With Increased Risk For Atrial Fibrillation, Karolinska Institute Study

Myriad RBM, Inc. To Downsize And Move Operations To Austin, Texas

Welichem Announces Termination Of Asset Purchase Agreement And Update On Compulsory Acquisition

HIV Rates Declining In U.S., Centers for Disease Control and Prevention (CDC) Reveals

Health Canada Approves Kane Biotech Inc.'s DispersinB® For Human Use

Eli Lilly and Company To Cut Up To 100 Indy Jobs, Send Some Work Overseas

Monsanto Company Should Lose Some Battles To Win The War Over GMOs

Taiho Pharmaceutical Invests US $30 Million In

Biogen, Inc. Second Quarter 2014 Revenues Increase 40% To $2.4 Billion; Company Raises Financial Guidance For The Year

Galena Biopharma Gives Sales Team Another Useless Product To Promote

Shire Share Price: Chief Executive Set For $10 Million 'Golden Hello'

ArmaGen Technologies, Inc. Licenses AGT-182 Rights To For Up To $225M

ViiV Healthcare: HIV Combo Therapy Candidate Fails Phase 3

U.S. Gilead Sciences, Inc. Approves FDA's Zydelig® (idelalisib) For Relapsed Chronic Lymphocytic Leukemia, Follicular Lymphoma And Small Lymphocytic Lymphoma

Potential Genetic Link Between Epilepsy, Neurodegenerative Disorders, University of Iowa Study

Sofinnova Ventures Raises $500 Million Biotech Venture Fund

SD Researchers Top Compensation List

Zenith Epigenetics Appoints Julie Cherrington As President And CEO

Mela Sciences Announces $27.3 Million Private Placement Of Preferred Stock, Debentures And Warrants

What Clinical Trials? Many Study Results Remain Under Wraps

ConMed Corporation Announces Leadership Transition

FDA Approves Eagle Pharmaceuticals' Ryanodex® For The Treatment Of Malignant Hyperthermia

Mylan Inc.'s Overseas Move Will Lower Tax Rate

Major Advance In Pipeline: Positive Topline Phase 3 Results For brivaracetam In Epilepsy Patients With Partial-Onset Seizures

University of Pittsburgh-Led Study Suggests Cystic Fibrosis Is Two Diseases, One Doesn???t Affect Lungs

FDA Grants Genentech???s Avastin Priority Review For Recurrent Platinum-Resistant Ovarian Cancer

Aduro Biotech Receives Breakthrough Therapy Designation From FDA For Innovative Pancreatic Cancer Combination Immunotherapy

Migraine Treatment Innovations Still Have Ways To Go

Young Women With A Heart Attack Continue To Fare Worse Than Men, Yale University School Of Medicine Study

Probiotics May Help People With High Blood Pressure, Griffith University Study

Johnson & Johnson CEO: We Have No Plans To Leave The U.S.

In Asthma, It's Not Just What You Smell, But What You Think You Smell, Monell Chemical Senses Center Study

New Research Links Bad Diet To Loss Of Smell, Florida State University Study

Baxter International, Inc. Initiates Voluntary Worldwide Recall Of Four Lots Of IV Solutions Due To The Presence Of Particulate Matter

Antipsychotic Drugs Linked To Slight Decrease In Brain Volume, University of Cambridge Study

How Much Will Those Allergan Inc. Cost Cuts Really Help?

Neogen Corporation Announces Quarterly Earnings Results, Misses Estimates By $0.02 EPS


    Read more..